Dirk Vordermark

7.6k total citations
222 papers, 4.7k citations indexed

About

Dirk Vordermark is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Dirk Vordermark has authored 222 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Pulmonary and Respiratory Medicine, 74 papers in Oncology and 42 papers in Molecular Biology. Recurrent topics in Dirk Vordermark's work include Advanced Radiotherapy Techniques (32 papers), Cancer, Hypoxia, and Metabolism (32 papers) and Glioma Diagnosis and Treatment (21 papers). Dirk Vordermark is often cited by papers focused on Advanced Radiotherapy Techniques (32 papers), Cancer, Hypoxia, and Metabolism (32 papers) and Glioma Diagnosis and Treatment (21 papers). Dirk Vordermark collaborates with scholars based in Germany, Austria and United States. Dirk Vordermark's co-authors include Michael Flentje, Matthias Bache, Matthias Kappler, Harun M. Said, Kurt Baier, Oliver Kölbl, Astrid Katzer, Matthias Gückenberger, Henri Wichmann and J. Martin Brown and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Dirk Vordermark

207 papers receiving 4.6k citations

Peers

Countries citing papers authored by Dirk Vordermark

Since Specialization

Citations

This map shows the geographic impact of Dirk Vordermark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk Vordermark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk Vordermark more than expected).

Fields of papers citing papers by Dirk Vordermark

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dirk Vordermark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk Vordermark. The network helps show where Dirk Vordermark may publish in the future.

Co-authorship network of co-authors of Dirk Vordermark

This figure shows the co-authorship network connecting the top 25 collaborators of Dirk Vordermark. A scholar is included among the top collaborators of Dirk Vordermark based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dirk Vordermark. Dirk Vordermark is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Translation, adaptation, and validation of the Care Coordination Instrument for cancer patients 2025 ·BMC Health Services Research ·(unknown), Anke Steckelberg, (unknown), Andreas Wienke, Heike Schmidt, Dirk Vordermark, Patrick Michl, C. Benedikt Westphalen, (unknown)	0
2	Population based study on the progress in survival of primarily metastatic lung cancer patients in Germany 2024 ·Scientific Reports ·(unknown), (unknown), Dirk Vordermark, (unknown), Daniel Medenwald	1
3	Correlation of Increased Soluble Tumor Necrosis Factor Receptor 1 with Mortality and Dependence on Treatment in Non-Small-Cell Lung Cancer Patients: A Longitudinal Cohort Study 2024 ·Cancers ·(unknown), (unknown), Frank Bernhard Kraus, C. Ostheimer, Dirk Vordermark, Rafael Mikolajczyk, Barbara Seliger, Daniel Medenwald	0
4	Combination of Betulinic Acid Fragments and Carbonic Anhydrase Inhibitors—A New Drug Targeting Approach 2024 ·Pharmaceutics ·Matthias Bache, (unknown), Andreas Thiel, (unknown), (unknown), (unknown), Antje Güttler, (unknown), Thomas Mueller, Dirk Vordermark, Iris Thondorf, René Csük, Reinhard Paschke	0
5	Statement of the Uterus Commission of the Gynecological Oncology Working Group (AGO) on Neoadjuvant Chemotherapy Prior to Definitive Radiochemotherapy in Patients with Locally Advanced Cervical Cancer 2024 ·Geburtshilfe und Frauenheilkunde ·Clemens Tempfer, Tanja Fehm, Dirk Vordermark, (unknown), Matthias W. Beckmann, Dominik Denschlag, Sara Y. Brucker, Markus Wallwiener, Michael Eichbaum, Beyhan Ataseven, Peter Hillemanns, (unknown)	1
6	The role of radiotherapy in the updated German S2k guideline for management of Merkel cell carcinoma 2023 ·Strahlentherapie und Onkologie ·Dirk Vordermark, Ulrike Höller	1
7	Medical Needs and Therapeutic Options for Melanoma Patients Resistant to Anti-PD-1-Directed Immune Checkpoint Inhibition 2023 ·Cancers ·Jessica C. Hassel, Lisa Zimmer, (unknown), Thomas Eigentler, Friedegund Meier, Peter Mohr, Tobias Pukrop, Alexander Roesch, Dirk Vordermark, Christina Wendl, Ralf Gutzmer	6
8	Feasibility of a simultaneously integrated boost concept for hypofractionated stereotactic radiotherapy of unresected brain metastases 2023 ·Radiation Oncology ·(unknown), Stephan Ensminger, (unknown), Martin Janich, (unknown), Dirk Vordermark, (unknown)	2
9	S2k‐Leitlinie – Merkelzellkarzinom – Update 2022 2023 ·JDDG Journal der Deutschen Dermatologischen Gesellschaft ·Jürgen C. Becker, Ambros J. Beer, (unknown), Thomas Eigentler, Michael J. Flaig, Thilo Gambichler, Stephan Grabbe, Ulrike Höller, Bernhard Klumpp, Stephan Lang, Claudia Pföhler, Christian Posch, Vikas Prasad, Peter Schlattmann, Sylke Schneider‐Burrus, (unknown), Patrick Terheyden, (unknown), Dirk Vordermark, Selma Ugurel	2
10	Factors associated with overall survival, progression-free survival and toxicity in patients with small cell lung cancer and thoracic irradiation in a clinical real-world setting 2023 ·Radiation Oncology ·(unknown), Dirk Vordermark, (unknown), Daniel Medenwald	2
11	Plasma β‐synuclein, GFAP, and neurofilaments in patients with malignant gliomas undergoing surgical and adjuvant therapy 2023 ·Annals of Clinical and Translational Neurology ·Samir Abu‐Rumeileh, Lorenzo Barba, Matthias Bache, Steffen Halbgebauer, Patrick Oeckl, Petra Steinacker, Antje Güttler, Jacqueline Keßler, (unknown), Christian Strauß, Dirk Vordermark, Markus Otto	6
12	Development and Evaluation of a Multimodal Supportive Intervention for Promoting Physical Function in Older Patients with Cancer 2022 ·Cancers ·(unknown), (unknown), (unknown), (unknown), Gabriele I. Stangl, (unknown), Daniel Medenwald, Dirk Vordermark, Anke Steckelberg, Heike Schmidt	3
13	SESN2 Knockdown Increases Betulinic Acid-Induced Radiosensitivity of Hypoxic Breast Cancer Cells 2022 ·Cells ·Antje Güttler, Claus Weinholdt, (unknown), (unknown), (unknown), (unknown), (unknown), Jacqueline Keßler, Matthias Kappler, Ivo Große, Dirk Vordermark, Matthias Bache	3
14	MSBA-S – A pentacyclic sulfamate as a new option for radiotherapy of human breast cancer cells 2021 ·European Journal of Medicinal Chemistry ·(unknown), Antje Güttler, (unknown), Immo Serbian, (unknown), (unknown), Jacqueline Keßler, (unknown), Reinhard Paschke, René Csük, Dirk Vordermark, Matthias Bache	11
15	<p>Development and Validation of an Information Leaflet on Oral Care for Irradiated Patients</p> 2020 ·Patient Preference and Adherence ·(unknown), Ramona Schweyen, Dirk Vordermark, Bernd Leplow, Jeremias Hey	9
16	Benefit from surgery with additional radiotherapy in N1 head and neck cancer at the time of IMRT: A population-based study on recent developments 2020 ·PLoS ONE ·(unknown), C. Ostheimer, (unknown), Dirk Vordermark, Daniel Medenwald	8
17	Investigation of the Prognostic Role of Carbonic Anhydrase 9 (CAIX) of the Cellular mRNA/Protein Level or Soluble CAIX Protein in Patients with Oral Squamous Cell Carcinoma 2019 ·International Journal of Molecular Sciences ·Alexander W. Eckert, (unknown), Daniel Bethmann, Johanna Kotrba, (unknown), Swetlana Rot, Matthias Bache, Udo Bilkenroth, (unknown), Thomas Greither, Claudia Wickenhauser, Dirk Vordermark, Helge Täubert, Matthias Kappler	20
18	Synthesis and biological investigation of new carbonic anhydrase IX (CAIX) inhibitors 2018 ·Chemico-Biological Interactions ·(unknown), (unknown), (unknown), Matthias Bache, Franziska Seifert, René Csük, Dirk Vordermark, Reinhard Paschke	23
19	mRNA expression levels of hypoxia-induced and stem cell-associated genes in human glioblastoma 2015 ·Oncology Reports ·Matthias Bache, Swetlana Rot, Jacqueline Keßler, Antje Güttler, Henri Wichmann, Thomas Greither, Sven Wach, Helge Täubert, Ariane Söling, Udo Bilkenroth, Matthias Kappler, Dirk Vordermark	28
20	Quality of Training in Radiation Oncology in Germany 2008 ·Strahlentherapie und Onkologie ·R. Semrau, (unknown), Markus Adam, Nicolaus Andratschke, Thomas Brunner, Frank Heinzelmann, Guido Hildebrandt, Dirk Vordermark, Daniel Zips	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact